2023 - Research.com Medicine in Sweden Leader Award
2023 - Research.com Microbiology in Sweden Leader Award
2022 - Research.com Microbiology in Sweden Leader Award
His primary scientific interests are in Immunology, Internal medicine, Eosinophil, Eosinophil cationic protein and Cardiology. His Immunology research includes themes of Respiratory disease and Bronchoalveolar lavage. The concepts of his Eosinophil study are interwoven with issues in Biochemistry and Granulocyte.
The Eosinophil cationic protein study combines topics in areas such as Eosinophilia, Molecular biology and Myeloperoxidase, Eosinophil peroxidase. His Cardiology research focuses on Low molecular weight heparin and how it connects with Anticoagulant. Per Venge interconnects Lipocalin and Pathology in the investigation of issues within Acute-phase protein.
Per Venge mostly deals with Immunology, Internal medicine, Eosinophil cationic protein, Eosinophil and Cardiology. His study in Immunology focuses on Asthma, Myeloperoxidase, Granulocyte, Allergy and Inflammation. His research in Myeloperoxidase focuses on subjects like Lactoferrin, which are connected to Lysozyme.
The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine. His studies deal with areas such as Molecular biology, Biochemistry, Major basic protein and Eosinophil peroxidase as well as Eosinophil cationic protein. His Eosinophil study combines topics from a wide range of disciplines, such as Eosinophilia, Pathology and Chemotaxis.
His main research concerns Internal medicine, Immunology, Cardiology, Troponin I and Cardiac troponin. Per Venge interconnects Gastroenterology, Endocrinology and Surgery in the investigation of issues within Internal medicine. His Immunology research is multidisciplinary, relying on both Biomarker and Lipocalin.
His research investigates the link between Cardiology and topics such as Disease that cross with problems in Lung. His Eosinophil cationic protein and Eosinophil-derived neurotoxin study are his primary interests in Eosinophil. He works mostly in the field of Eosinophil cationic protein, limiting it down to concerns involving Molecular biology and, occasionally, Antibody.
Per Venge focuses on Internal medicine, Cardiology, Immunology, Myocardial infarction and Cardiac troponin. His work carried out in the field of Internal medicine brings together such families of science as Surgery and Intensive care medicine. His work in the fields of Cardiology, such as Troponin T, Heart failure and Troponin, intersects with other areas such as Risk assessment.
He frequently studies issues relating to COPD and Immunology. His study in the fields of Acute coronary syndrome and Myocardial infarction diagnosis under the domain of Myocardial infarction overlaps with other disciplines such as Diagnostic methods. His study looks at the relationship between Eosinophil and topics such as Respiratory distress, which overlap with Eosinophil cationic protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Eosinophilic inflammation in asthma.
J Bousquet;P Chanez;J Y Lacoste;G Barnéon.
The New England Journal of Medicine (1990)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Bertil Lindahl;Henrik Toss;Agneta Siegbahn;Per Venge.
The New England Journal of Medicine (2000)
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.
Jgr Demonchy;Hf Kauffman;P Venge;Gh Koeter.
The American review of respiratory disease (1985)
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Björn Zethelius;Lars Berglund;Johan Sundström;Erik Ingelsson.
The New England Journal of Medicine (2008)
Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers
Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry.
American Journal of Respiratory and Critical Care Medicine (2011)
How to use high-sensitivity cardiac troponins in acute cardiac care
Kristian Thygesen;Johannes Mair;Evangelos Giannitsis;Christian Mueller.
European Heart Journal (2012)
Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease
Bertil Lindahl;Per Venge;Lars Wallentin.
N-Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy
Stefan K. James;Bertil Lindahl;Agneta Siegbahn;Mats Stridsberg.
Low-molecular-weight heparin during instability in coronary artery disease
L Wallentin;J Ohlsson;E Swahn;E Karlsson.
The Lancet (1996)
Recommendations for the use of cardiac troponin measurement in acute cardiac care
Kristian Thygesen;Johannes Mair;Hugo Katus;Mario Plebani.
European Heart Journal (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: